Zengmiao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zengmiao Wang has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Bingying Li
Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, State Key Laboratory of Remote Sensing and Digital Earth, Center for Global Change and Public Health, Faculty of Geographical Science, Beijing Normal University, Beijing, China
3 shared publicationsPeiyi Wu
Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, State Key Laboratory of Remote Sensing and Digital Earth, Center for Global Change and Public Health, Faculty of Geographical Science, Beijing Normal University, Beijing, China
3 shared publicationsYonghong Liu
Affiliation Beijing Center for Disease Prevention and Control, Beijing, China
3 shared publicationsYuxi Ge
Affiliation Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Research Center for Respiratory Infectious Diseases, State Key Laboratory of Remote Sensing and Digital Earth, Center for Global Change and Public Health, Beijing Normal University, Beijing, China
3 shared publicationsZiqin Zhou
Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Research Center for Respiratory Infectious Diseases, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Center for Global Change and Public Health, Faculty of Geographical Science, Beijing Normal University, Beijing, China
3 shared publicationsFanghua Hao
Central China Normal University, Wuhan, China
2 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Global disparities in COVID-19 vaccine coverage associated with trajectories of SARS-CoV-2 adaptation
Vaccination serves as an effective intervention for health promotion and disease prevention across the socioecological systems and has played an important role during the COVID-19 pandemic. However, global disparities in vaccine coverage have increased uncertainty about the trajectories of viral adaptation, and the potential interplay between SARS-CoV-2 adaptation and vaccine rollout warrants further quantification. Using over 13 million SARS-CoV-2 genomes across 86 countries from March 2020 to September 2022, we analyzed nonlinear associations between SARS-CoV-2 adaptation and vaccination coverage, considering public health and social measures, international travel, and infection dynamics, before and after the emergence of Omicron. Additionally, we examined the relationship between SARS-CoV-2 adaptation and COVID-19 mortality. During the pre-Omicron period, we found positive associations between nonsynonymous to synonymous divergence (dN/dS) ratios in the S1 subunit and medium levels of adjusted vaccine coverage (effect size: 0.96 [95% CI 0.47, 1.45]), while the association became insignificant at high levels (effect size: -1.89 [95% CI -4.20, 0.43]). However, no significant associations were found when Omicron dominated, possibly due to the immune escape ability of Omicron variants and the complex immune landscape shaped by mass hybrid immunity. Moreover, we observed evidence of dynamic interdependence and positive correlations between COVID-19 mortality and SARS-CoV-2 adaptation, with COVID-19 mortality interpreted as a proxy for uncontrolled viral spread. Our findings suggest a complex nonlinear relationship between vaccine-induced immunity and SARS-CoV-2 adaptation, with high vaccine coverage potentially linked to lower positive selection. We also observed directional coupling between COVID-19 mortality and SARS-CoV-2 adaptation. This may have implications for fair and fast vaccination in pandemic preparedness and response. Not applicable.
- 22 June 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessGlobal disparities in COVID-19 vaccine coverage associated with trajectories of SARS-CoV-2 adaptation
Vaccination serves as an effective intervention for health promotion and disease prevention across the socioecological systems and has played an important role during the COVID-19 pandemic. However, global disparities in vaccine coverage have increased uncertainty about the trajectories of viral adaptation, and the potential interplay between SARS-CoV-2 adaptation and vaccine rollout warrants further quantification. Using over 13 million SARS-CoV-2 genomes across 86 countries from March 2020 to September 2022, we analyzed nonlinear associations between SARS-CoV-2 adaptation and vaccination coverage, considering public health and social measures, international travel, and infection dynamics, before and after the emergence of Omicron. Additionally, we examined the relationship between SARS-CoV-2 adaptation and COVID-19 mortality. During the pre-Omicron period, we found positive associations between nonsynonymous to synonymous divergence (dN/dS) ratios in the S1 subunit and medium levels of adjusted vaccine coverage (effect size: 0.96 [95% CI 0.47, 1.45]), while the association became insignificant at high levels (effect size: -1.89 [95% CI -4.20, 0.43]). However, no significant associations were found when Omicron dominated, possibly due to the immune escape ability of Omicron variants and the complex immune landscape shaped by mass hybrid immunity. Moreover, we observed evidence of dynamic interdependence and positive correlations between COVID-19 mortality and SARS-CoV-2 adaptation, with COVID-19 mortality interpreted as a proxy for uncontrolled viral spread. Our findings suggest a complex nonlinear relationship between vaccine-induced immunity and SARS-CoV-2 adaptation, with high vaccine coverage potentially linked to lower positive selection. We also observed directional coupling between COVID-19 mortality and SARS-CoV-2 adaptation. This may have implications for fair and fast vaccination in pandemic preparedness and response. Not applicable.
- Open Access
- 12 January 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (1) , e1013582
Characterization of the heterogeneity in SARS-CoV-2 fitness dynamics via graph representation learning
Understanding the heterogeneity of population-level viral fitness dynamics, which reflect the interplay between intrinsic viral properties and population immunity, is critical for pandemic preparedness. However, how these dynamics vary across diverse immune backgrounds and mutational landscapes remain poorly characterized. We present Geno-GNN, a graph representation learning approach for retrospectively characterizing the viral fitness dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Geno-GNN accurately predicts angiotensin-converting enzyme 2 (ACE2) binding affinity and immune escape potential across multiple external datasets. Using Geno-GNN, we identified temporal patterns in SARS-CoV-2 fitness and detected varying rates of fitness change associated with distinct immune backgrounds. Virtual mutation scanning revealed two fitness trajectories: broad immune evasion at the cost of ACE2 affinity and ACE2 affinity maintenance at or above the Wuhan-Hu-1 level along with moderate immune escape. Notably, real-world SARS-CoV-2 variants predominantly followed the latter trajectory, sustaining ACE2 affinity via fixed mutations. These findings underscore the heterogeneous, immune-contextualized nature of viral fitness dynamics and the complex evolutionary pathways of SARS-CoV-2.
- 12 January 2026
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 22 (1) , e1013582
Open AccessCharacterization of the heterogeneity in SARS-CoV-2 fitness dynamics via graph representation learning
Understanding the heterogeneity of population-level viral fitness dynamics, which reflect the interplay between intrinsic viral properties and population immunity, is critical for pandemic preparedness. However, how these dynamics vary across diverse immune backgrounds and mutational landscapes remain poorly characterized. We present Geno-GNN, a graph representation learning approach for retrospectively characterizing the viral fitness dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Geno-GNN accurately predicts angiotensin-converting enzyme 2 (ACE2) binding affinity and immune escape potential across multiple external datasets. Using Geno-GNN, we identified temporal patterns in SARS-CoV-2 fitness and detected varying rates of fitness change associated with distinct immune backgrounds. Virtual mutation scanning revealed two fitness trajectories: broad immune evasion at the cost of ACE2 affinity and ACE2 affinity maintenance at or above the Wuhan-Hu-1 level along with moderate immune escape. Notably, real-world SARS-CoV-2 variants predominantly followed the latter trajectory, sustaining ACE2 affinity via fixed mutations. These findings underscore the heterogeneous, immune-contextualized nature of viral fitness dynamics and the complex evolutionary pathways of SARS-CoV-2.
- Open Access
- 25 September 2025
- Published by Elsevier in One Health
- Vol. 21, 101224
Associations between the 2022 global mpox outbreak and multifaceted factors: A multi-geographical retrospective study
- 25 September 2025
- Published by Elsevier in One Health
- Vol. 21, 101224
Open AccessAssociations between the 2022 global mpox outbreak and multifaceted factors: A multi-geographical retrospective study
- Open Access
- 18 September 2023
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 19 (9) , e1011492
Marginal effects of public health measures and COVID-19 disease burden in China: A large-scale modelling study
China had conducted some of the most stringent public health measures to control the spread of successive SARS-CoV-2 variants. However, the effectiveness of these measures and their impacts on the associated disease burden have rarely been quantitatively assessed at the national level. To address this gap, we developed a stochastic age-stratified metapopulation model that incorporates testing, contact tracing and isolation, based on 419 million travel movements among 366 Chinese cities. The study period for this model began from September 2022. The COVID-19 disease burden was evaluated, considering 8 types of underlying health conditions in the Chinese population. We identified the marginal effects between the testing speed and reduction in the epidemic duration. The findings suggest that assuming a vaccine coverage of 89%, the Omicron-like wave could be suppressed by 3-day interval population-level testing (PLT), while it would become endemic with 4-day interval PLT, and without testing, it would result in an epidemic. PLT conducted every 3 days would not only eliminate infections but also keep hospital bed occupancy at less than 29.46% (95% CI, 22.73–38.68%) of capacity for respiratory illness and ICU bed occupancy at less than 58.94% (95% CI, 45.70–76.90%) during an outbreak. Furthermore, the underlying health conditions would lead to an extra 2.35 (95% CI, 1.89–2.92) million hospital admissions and 0.16 (95% CI, 0.13–0.2) million ICU admissions. Our study provides insights into health preparedness to balance the disease burden and sustainability for a country with a population of billions.
- 18 September 2023
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 19 (9) , e1011492
Open AccessMarginal effects of public health measures and COVID-19 disease burden in China: A large-scale modelling study
China had conducted some of the most stringent public health measures to control the spread of successive SARS-CoV-2 variants. However, the effectiveness of these measures and their impacts on the associated disease burden have rarely been quantitatively assessed at the national level. To address this gap, we developed a stochastic age-stratified metapopulation model that incorporates testing, contact tracing and isolation, based on 419 million travel movements among 366 Chinese cities. The study period for this model began from September 2022. The COVID-19 disease burden was evaluated, considering 8 types of underlying health conditions in the Chinese population. We identified the marginal effects between the testing speed and reduction in the epidemic duration. The findings suggest that assuming a vaccine coverage of 89%, the Omicron-like wave could be suppressed by 3-day interval population-level testing (PLT), while it would become endemic with 4-day interval PLT, and without testing, it would result in an epidemic. PLT conducted every 3 days would not only eliminate infections but also keep hospital bed occupancy at less than 29.46% (95% CI, 22.73–38.68%) of capacity for respiratory illness and ICU bed occupancy at less than 58.94% (95% CI, 45.70–76.90%) during an outbreak. Furthermore, the underlying health conditions would lead to an extra 2.35 (95% CI, 1.89–2.92) million hospital admissions and 0.16 (95% CI, 0.13–0.2) million ICU admissions. Our study provides insights into health preparedness to balance the disease burden and sustainability for a country with a population of billions.
- Open Access
- 12 October 2022
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 19 (195)
Assessing the asymptomatic proportion of SARS-CoV-2 infection with age in China before mass vaccination
Some asymptomatic individuals carrying SARS-CoV-2 can transmit the virus and contribute to outbreaks of COVID-19. Here, we use detailed surveillance data gathered during COVID-19 resurgences in six cities of China at the beginning of 2021 to investigate the relationship between asymptomatic proportion and age. Epidemiological data obtained before mass vaccination provide valuable insights into the nature of pathogenicity of SARS-CoV-2. The data were collected by multiple rounds of city-wide PCR testing with contact tracing, where each patient was monitored for symptoms through the whole course of infection. The clinical endpoint (asymptomatic or symptomatic) for each patient was recorded (the pre-symptomatic patients were classified as symptomatic). We find that the proportion of infections that are asymptomatic declines with age (coefficient = −0.006, 95% CI: −0.008 to −0.003,p< 0.01), falling from 42% (95% CI: 6–78%) in age group 0–9 years to 11% (95% CI: 0–25%) in age group greater than 60 years. Using an age-stratified compartment model, we show that this age-dependent asymptomatic pattern, together with the distribution of cases by age, can explain most of the reported variation in asymptomatic proportions among cities. Our analysis suggests that SARS-CoV-2 surveillance strategies should take account of the variation in asymptomatic proportion with age.
- 12 October 2022
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 19 (195)
Open AccessAssessing the asymptomatic proportion of SARS-CoV-2 infection with age in China before mass vaccination
Some asymptomatic individuals carrying SARS-CoV-2 can transmit the virus and contribute to outbreaks of COVID-19. Here, we use detailed surveillance data gathered during COVID-19 resurgences in six cities of China at the beginning of 2021 to investigate the relationship between asymptomatic proportion and age. Epidemiological data obtained before mass vaccination provide valuable insights into the nature of pathogenicity of SARS-CoV-2. The data were collected by multiple rounds of city-wide PCR testing with contact tracing, where each patient was monitored for symptoms through the whole course of infection. The clinical endpoint (asymptomatic or symptomatic) for each patient was recorded (the pre-symptomatic patients were classified as symptomatic). We find that the proportion of infections that are asymptomatic declines with age (coefficient = −0.006, 95% CI: −0.008 to −0.003,p< 0.01), falling from 42% (95% CI: 6–78%) in age group 0–9 years to 11% (95% CI: 0–25%) in age group greater than 60 years. Using an age-stratified compartment model, we show that this age-dependent asymptomatic pattern, together with the distribution of cases by age, can explain most of the reported variation in asymptomatic proportions among cities. Our analysis suggests that SARS-CoV-2 surveillance strategies should take account of the variation in asymptomatic proportion with age.
- Open Access
- 15 March 2021
- Published by Springer Nature in BMC Medicine
- Vol. 19 (1) , 1-7
A follow-up study shows that recovered patients with re-positive PCR test in Wuhan may not be infectious
Background: Previous studies showed that recovered coronavirus disease 2019 (COVID-19) patients can have a subsequent positive polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after they are discharged from the hospital. Understanding the epidemiological characteristics of recovered COVID-19 patients who have a re-positive test is vital for preventing a second wave of COVID-19. Methods: This retrospective study analyzed the epidemiological and clinical features of 20,280 COVID-19 patients from multiple centers in Wuhan who had a positive PCR test between December 31, 2019, and August 4, 2020. The RT-PCR test results for 4079 individuals who had close contact with the re-positive cases were also obtained. Results: In total, 2466 (12.16%) of the 20,280 patients had a re-positive SARS-CoV-2 PCR test after they were discharged from the hospital, and 4079 individuals had close contact with members of this patient group. All of these 4079 individuals had a negative SARS-CoV-2 PCR test. Conclusions: This retrospective study in Wuhan analyzed the basic characteristics of recovered COVID-19 patients with re-positive PCR test and found that these cases may not be infectious.
- 15 March 2021
- Published by Springer Nature in BMC Medicine
- Vol. 19 (1) , 1-7
Open AccessA follow-up study shows that recovered patients with re-positive PCR test in Wuhan may not be infectious
Background: Previous studies showed that recovered coronavirus disease 2019 (COVID-19) patients can have a subsequent positive polymerase chain reaction (PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after they are discharged from the hospital. Understanding the epidemiological characteristics of recovered COVID-19 patients who have a re-positive test is vital for preventing a second wave of COVID-19. Methods: This retrospective study analyzed the epidemiological and clinical features of 20,280 COVID-19 patients from multiple centers in Wuhan who had a positive PCR test between December 31, 2019, and August 4, 2020. The RT-PCR test results for 4079 individuals who had close contact with the re-positive cases were also obtained. Results: In total, 2466 (12.16%) of the 20,280 patients had a re-positive SARS-CoV-2 PCR test after they were discharged from the hospital, and 4079 individuals had close contact with members of this patient group. All of these 4079 individuals had a negative SARS-CoV-2 PCR test. Conclusions: This retrospective study in Wuhan analyzed the basic characteristics of recovered COVID-19 patients with re-positive PCR test and found that these cases may not be infectious.
- Open Access
- 13 January 2021
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11
A Novel Transcriptome Integrated Network Approach Identifies the Key Driver lncRNA Involved in Cell Cycle With Chromium (VI)-Treated BEAS-2B Cells
Hexavalent chromium [Cr(VI)] is a well-known occupational carcinogen, but the mechanisms contributing to DNA damage and cell cycle alternation have not been fully characterized. To study the dose-response effects of Cr(VI) on transcription, we exposed BEAS-2B cells to Cr(VI) at concentrations of 0.2, 0.6, and 1.8 μmol/L for 24 h. Here, we identified 1,484 differentially expressed genes (DEGs) in our transcript profiling data, with the majority of differentially expressed transcripts being downregulated. Our results also showed that these DEGs were enriched in pathways associated with the cell cycle, including DNA replication, chromatin assembly, and DNA repair. Using the differential expressed genes related to cell cycle, a weighted gene co-expression network was constructed and a key mRNA-lncRNA regulation module was identified under a scale-free network with topological properties. Additionally, key driver analysis (KDA) was applied to the mRNA-lncRNA regulation module to identify the driver genes. The KDA revealed that ARD3 (FDR = 1.46 × 10–22), SND1 (FDR = 5.24 × 10–8), and lnc-DHX32-2:1 (FDR = 1.43 × 10–17) were particularly highlighted in the category of G2/M, G1/S, and M phases. Moreover, several genes we identified exhibited great connectivity in our causal gene network with every key driver gene, including CDK14, POLA1, lnc-NCS1-2:1, and lnc-FOXK1-4:1 (all FDR < 0.05 in those phases). Together, these results obtained using mathematical approaches and bioinformatics algorithmics might provide potential new mechanisms involved in the cytotoxicity induced by Cr.
- 13 January 2021
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11
Open AccessA Novel Transcriptome Integrated Network Approach Identifies the Key Driver lncRNA Involved in Cell Cycle With Chromium (VI)-Treated BEAS-2B Cells
Hexavalent chromium [Cr(VI)] is a well-known occupational carcinogen, but the mechanisms contributing to DNA damage and cell cycle alternation have not been fully characterized. To study the dose-response effects of Cr(VI) on transcription, we exposed BEAS-2B cells to Cr(VI) at concentrations of 0.2, 0.6, and 1.8 μmol/L for 24 h. Here, we identified 1,484 differentially expressed genes (DEGs) in our transcript profiling data, with the majority of differentially expressed transcripts being downregulated. Our results also showed that these DEGs were enriched in pathways associated with the cell cycle, including DNA replication, chromatin assembly, and DNA repair. Using the differential expressed genes related to cell cycle, a weighted gene co-expression network was constructed and a key mRNA-lncRNA regulation module was identified under a scale-free network with topological properties. Additionally, key driver analysis (KDA) was applied to the mRNA-lncRNA regulation module to identify the driver genes. The KDA revealed that ARD3 (FDR = 1.46 × 10–22), SND1 (FDR = 5.24 × 10–8), and lnc-DHX32-2:1 (FDR = 1.43 × 10–17) were particularly highlighted in the category of G2/M, G1/S, and M phases. Moreover, several genes we identified exhibited great connectivity in our causal gene network with every key driver gene, including CDK14, POLA1, lnc-NCS1-2:1, and lnc-FOXK1-4:1 (all FDR < 0.05 in those phases). Together, these results obtained using mathematical approaches and bioinformatics algorithmics might provide potential new mechanisms involved in the cytotoxicity induced by Cr.
- Open Access
A follow-up study shows no new infections caused by patients with repeat positive of COVID-19 in Wuhan
Background It has been reported that a few recovered COVID-19 patients could suffer repeat positive, testing positive for the SARS-CoV-2 virus again after they were discharged from hospital. Understanding the epidemiological characteristics of patients with repeat positive is vital in preventing a second wave of COVID-19. Methods In this study, the epidemiological and clinical features for 20,280 COVID-19 patients from multiple centers between 31 December 2019 and 4 August 2020 in Wuhan were collected and followed. In addition, the RT-qPCR testing results for 4,079 individuals who had close contact with the patients suffering repeat positive were also obtained. Results 2,466 (12.16%) of 20,280 patients presented with a repeat positive of SARS-CoV-2 after they were discharged from hospital. 4,079 individuals had close contact with them. The PCR result were negative for the 4,079 individuals. Conclusions By a follow-up study in Wuhan, we show the basic characteristics of patients with repeat positive and no new infections caused by patients with repeat positive of COVID-19.
Open AccessA follow-up study shows no new infections caused by patients with repeat positive of COVID-19 in Wuhan
Background It has been reported that a few recovered COVID-19 patients could suffer repeat positive, testing positive for the SARS-CoV-2 virus again after they were discharged from hospital. Understanding the epidemiological characteristics of patients with repeat positive is vital in preventing a second wave of COVID-19. Methods In this study, the epidemiological and clinical features for 20,280 COVID-19 patients from multiple centers between 31 December 2019 and 4 August 2020 in Wuhan were collected and followed. In addition, the RT-qPCR testing results for 4,079 individuals who had close contact with the patients suffering repeat positive were also obtained. Results 2,466 (12.16%) of 20,280 patients presented with a repeat positive of SARS-CoV-2 after they were discharged from hospital. 4,079 individuals had close contact with them. The PCR result were negative for the 4,079 individuals. Conclusions By a follow-up study in Wuhan, we show the basic characteristics of patients with repeat positive and no new infections caused by patients with repeat positive of COVID-19.